Entecavir Efficiency in Chronic Hepatitis B

被引:0
|
作者
Grecu, Nicolae [1 ]
Preda, Carmen [1 ]
Soare, Alina [1 ]
Stefan, Gabriel [1 ]
Andrei, Stefan [1 ]
机构
[1] Univ Med & Pharm Carol Davila Bucharest, Bucharest, Romania
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
747
引用
收藏
页码:31 / 32
页数:2
相关论文
共 50 条
  • [41] Seroconversion of Hepatitis B Virus Surface Antigen in Chronic Hepatitis B Child Treated with Entecavir
    Li, Dong
    Wang, Junping
    Zhou, Junqing
    Wang, Yan
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2012, 4 (09) : 427 - 428
  • [42] Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance
    Lee, S.
    Ahn, S. H.
    Jung, K. S.
    Kim, D. Y.
    Kim, B. K.
    Kim, S. U.
    Baatarkhuu, O.
    Ku, H. J.
    Han, K.
    Park, J. Y.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (02) : 141 - 147
  • [43] Comparable efficacy with entecavir monotherapy and tenofovir-entecavir combination in chronic hepatitis B patients
    Baqai, Sumbella
    Proudfoot, James
    Xu, Ronghui
    Kane, Steve
    Clark, Margaret
    Gish, Robert
    BMJ OPEN GASTROENTEROLOGY, 2015, 2 (01):
  • [44] Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Fong, Tse-Ling
    Tien, Andy
    Jo, Kahee J.
    Chu, Danny
    Cheung, Eddie
    Mena, Edward A.
    Quang-Quoc Phan
    Yu, Andy S.
    Mohammed, Wafa
    Velasco, Andrew
    Vinh-Huy LeDuc
    Nguyen, Nickolas
    Han, Steven-Bui
    Chang, Mimi
    Bae, Ho S.
    Cho, Yong-Won
    Tong, Myron J.
    Cooper, Stewart L.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (11) : 3465 - 3472
  • [45] Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Tse-Ling Fong
    Andy Tien
    Kahee J. Jo
    Danny Chu
    Eddie Cheung
    Edward A. Mena
    Quang-Quoc Phan
    Andy S. Yu
    Wafa Mohammed
    Andrew Velasco
    Vinh-Huy LeDuc
    Nickolas Nguyen
    Steven-Bui Han
    Mimi Chang
    Ho S. Bae
    Yong-Won Cho
    Myron J. Tong
    Stewart L. Cooper
    Digestive Diseases and Sciences, 2015, 60 : 3465 - 3472
  • [46] Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection
    Lai, CL
    Rosmawati, M
    Lao, J
    Van Vlierberghe, H
    Anderson, FH
    Thomas, N
    Dehertogh, D
    GASTROENTEROLOGY, 2002, 123 (06) : 1831 - 1838
  • [47] Entecavir maleate versus entecavir in Chinese chronic hepatitis B predominantly genotype B or C: Results at week 144
    Xu, J. -H.
    Wang, S.
    Xu, Z. -N.
    Yu, Y. -Y.
    Si, C. -W.
    Zeng, Z.
    Li, J.
    Mao, Q.
    Zhang, D. -Z.
    Tang, H.
    Sheng, J. -F.
    Chen, X. -Y.
    Ning, Q.
    Shi, G. -F.
    Xie, Q.
    Zhang, X. -Q.
    Dai, J.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (10) : 877 - 884
  • [48] Entecavir reduces the incidence of hepatocellular carcinoma in patients with chronic hepatitis B
    Yasunaka, Tetsuya
    Ikeda, Fusao
    Takaki, Akinobu
    Seno, Tomonori
    Takaguchi, Koichi
    Yamamoto, Kazuhide
    HEPATOLOGY, 2014, 60 : 1096A - 1096A
  • [49] Efficacy of Entecavir therapy in elderly patients with chronic hepatitis B infection
    Tan, You-wen
    Ge, Guo-hong
    Sun, Li
    Zhou, Xing-bei
    Peng, Pen-li
    Chen, Li
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2014, 18 (06): : 691 - 692
  • [50] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B
    Choi, Won-Mook
    Choi, Jonggi
    Wong, Grace Lai-Hung
    Han, Seungbong
    Lim, Young-Suk
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 87